bioAffinity Technologies, Inc. (BIAFW)

US — Healthcare Sector
Peers: BIAF  XGN  APDN  RNVA  AAPJ  DPUI  CDSG 

Automate Your Wheel Strategy on BIAFW

With Tiblio's Option Bot, you can configure your own wheel strategy including BIAFW - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol BIAFW
  • Rev/Share 0.3198
  • Book/Share -0.0889
  • PB -2.8384
  • Debt/Equity -0.3137
  • CurrentRatio 0.6448
  • ROIC -4.0171

 

  • MktCap 7183178.0
  • FreeCF/Share -0.3226
  • PFCF -0.927
  • PE -0.5187
  • Debt/Assets 0.141
  • DivYield 0
  • ROE -9.302

 

  • Rating B-
  • Score 2
  • Recommendation Sell
  • P/E Score 1
  • DCF Score 5
  • P/B Score 1
  • D/E Score 1

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

About bioAffinity Technologies, Inc. (BIAFW)

  • IPO Date
  • Website http://www.bioaffinitytech.com
  • Industry Medical - Diagnostics & Research
  • CEO Maria Zannes
  • Employees 57
bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The firm develops proprietary in-vitro diagnostic tests and targeted cancer therapeutics using breakthrough technology that preferentially targets cancer cells. The company was founded on March 26, 2014 and is headquartered in San Antonio, TX.